FJ
Flynn James E cut its BBOT stake below 5%
Flynn James E reported owning 3.9% of BridgeBio Oncology Therapeutics, Inc. (BBOT) (3,138,167 shares) in a Schedule 13G filed Nov 13, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 13, 2026
- Source
- Schedule 13G